WebFOLFIRINOX (FFX) and Gemcitabine plus nab-paclitaxel (GNP) are approved as first-line metastatic treatment in PCa. The aim of this study was to compare the clinical outcomes, … Web*3 folfirinox(フォルフィリノックス)療法 5-fu、オキサリプラチン、イリノテカン、ロイコボリンを併用した化学療法。切除不能進行再発 膵癌に対してよく用いられる。奏効 …
臨床試験登録 - UMIN
WebThe frequency of grade III to IV febrile neutropenia was higher in the FFX group (18% vs. 11%, P=0.040), and that of peripheral neuropathy was higher in the GNP group (8% vs. … WebJan 4, 2016 · 切除不能膵癌に対するfolfirinox治療の実際 17:887 table 3 accord 114)と日本の治験8)の比較 accord 11 日本の治験 n 171(folfirinox群) 36 有効性 奏効率(%) 31.6 38.9 病勢制御率(%) 70.2 69.4 奏効期間 5.9(月) 170(日) 生存期間中央値(月) 11.1 10.7 有害事象 gacha heat farting
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel …
Webstatic or recurrent pancreatic cancer treated with GnP or mFFX as the first-line chemotherapy between March 2014 and December 2024 in our hospital. Treatment outcomes were compared using propensity score matching to adjust for age, sex, performance status, carcinoembryonic antigen levels, carbohydrate antigen 19-9 levels, … WebFeb 2, 2024 · Drug toxicity in the GnP group was less than in the FOLFIRINOX group. Conclusions: Efficacy and safety of GnP compare favorably to those of FOLFIRINOX in … WebWhether the prognosis of PC with peritoneal metastasis has improved with the advent of gemcitabine plus nab-paclitaxel (GnP) and modified FOLFIRINOX (mFFX) is uncertain. The aim of this study was to evaluate the improvements in treatment outcomes of PC with peritoneal metastasis. ... The administration of GnP or mFFX, performance status, and ... gacha heat fart poop and pee